| DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs M Sisteré-Oró, S López-Serrano, V Veljkovic, S Pina-Pedrero, ... PLoS One 14 (9), e0222201, 2019 | 23 | 2019 |
| Protective effect of a polyvalent influenza DNA vaccine in pigs I Karlsson, M Borggren, MW Rosenstierne, R Trebbien, JA Williams, ... Veterinary immunology and immunopathology 195, 25-32, 2018 | 23 | 2018 |
| Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 A Barreiro, A Prenafeta, G Bech-Sabat, M Roca, EP Mur, R March, ... Iscience 26 (3), 2023 | 14* | 2023 |
| Identification and characterization of swine influenza virus h1n1 variants generated in vaccinated and nonvaccinated, challenged pigs Á López-Valiñas, M Sisteré-Oró, S López-Serrano, L Baioni, A Darji, ... Viruses 13 (10), 2087, 2021 | 14 | 2021 |
| Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination M Sisteré-Oró, N Andrade, DDJ Wortmann, J Du, N Garcia-Giralt, ... Frontiers in Immunology 13, 994173, 2022 | 13 | 2022 |
| Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge M Sisteré-Oró, J Vergara-Alert, T Stratmann, S López-Serrano, ... PLoS One 14 (3), e0212431, 2019 | 9 | 2019 |
| Brief research report: anti-SARS-CoV-2 immunity in long lasting responders to cancer immunotherapy through mrna-based COVID-19 vaccination M Sisteré-Oró, DDJ Wortmann, N Andrade, A Aguilar, ... Frontiers in immunology 13, 908108, 2022 | 6 | 2022 |
| Conserved HA-peptides expressed along with flagellin in Trichoplusia ni larvae protects chicken against intranasal H7N1 HPAIV challenge M Sisteré-Oró, S Martínez-Pulgarín, D Solanes, V Veljkovic, ... Vaccine 38 (3), 416-422, 2020 | 6 | 2020 |
| Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate M Sisteré-Oró, GK Pedersen, L Córdoba, S López-Serrano, ... Veterinary research 51, 1-11, 2020 | 5 | 2020 |
| Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate A Moros, A Prenafeta, A Barreiro, E Perozo, A Fernandez, M Canete, ... bioRxiv, 2023.01. 19.524684, 2023 | 3 | 2023 |
| Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates A Prenafeta, G Bech-Sàbat, A Moros, A Barreiro, A Fernández, M Cañete, ... Iscience 26 (7), 2023 | 2 | 2023 |
| Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium L Marcos-Villar, B Perdiguero, S Anthiya, ML Borrajo, G Lou, ... npj Vaccines 9, 2024 | 1* | 2024 |
| Pan‐pox‐specific T‐cell responses in HIV‐1‐infected individuals after JYNNEOS vaccination M Sisteré‐Oró, J Du, DDJ Wortmann, MD Filippi, E Cañas‐Ruano, ... Journal of Medical Virology 96 (1), e29317, 2024 | 1 | 2024 |
| Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA) I Esteban, C Pastor-Quiñones, L Usero, E Aurrecoechea, L Franceschini, ... Vaccines 12 (1), 15, 2023 | | 2023 |
| Towards a universal influenza vaccine: generation and evaluation of vaccine formulations based on HA-epitopes in different influenza hosts M Sisteré-Oró | | 2019 |
